Neuroplasticity is disrupted in depression.3 In response, the brain attempts to restore neuroplasticity by increasing the S100B levels in depressive patients.19 However, the compensatory mechanism varies among depressive patients.19 As a result, some depressive patients have high concentrations of S100B, while others have low concentrations. The gene discussed is S100B; the disease is major depressive disorder.